Retratutide 5mg

Retatrutide is a GGG tri-agonist that simultaneously targets GLP-1, GIP, and glucagon receptors. This unique mechanism of action provides a comprehensive approach to research, distinguishing it from earlier GLP-1 agonists. Its versatility makes it a valuable tool for advanced experimental studies.

Key Features

• High-purity research-grade peptide
• Supplied as a lyophilized powder
• Multi-receptor targeting (GLP-1, GIP, and glucagon) for cutting-edge research

Contents and Packaging
Each vial contains 5 mg of Retatrutide in lyophilized powder form. Store at 2-8°C to ensure stability.

Disclaimer
For laboratory research use only. Not intended for human consumption or medical applications.